GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dianthus Therapeutics Inc (NAS:DNTH) » Definitions » PB Ratio

Dianthus Therapeutics (Dianthus Therapeutics) PB Ratio : 2.07 (As of May. 16, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Dianthus Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-16), Dianthus Therapeutics's share price is $26.25. Dianthus Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 was $12.70. Hence, Dianthus Therapeutics's PB Ratio of today is 2.07.

The historical rank and industry rank for Dianthus Therapeutics's PB Ratio or its related term are showing as below:

DNTH' s PB Ratio Range Over the Past 10 Years
Min: 0.6   Med: 1.57   Max: 2.8
Current: 2.07

During the past 3 years, Dianthus Therapeutics's highest PB Ratio was 2.80. The lowest was 0.60. And the median was 1.57.

DNTH's PB Ratio is ranked better than
55.75% of 1322 companies
in the Biotechnology industry
Industry Median: 2.54 vs DNTH: 2.07

Back to Basics: PB Ratio


Dianthus Therapeutics PB Ratio Historical Data

The historical data trend for Dianthus Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dianthus Therapeutics PB Ratio Chart

Dianthus Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
PB Ratio
- - 0.91

Dianthus Therapeutics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial - - 1.14 0.91 2.36

Competitive Comparison of Dianthus Therapeutics's PB Ratio

For the Biotechnology subindustry, Dianthus Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dianthus Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dianthus Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Dianthus Therapeutics's PB Ratio falls into.



Dianthus Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Dianthus Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=26.25/12.699
=2.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Dianthus Therapeutics  (NAS:DNTH) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Dianthus Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Dianthus Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dianthus Therapeutics (Dianthus Therapeutics) Business Description

Traded in Other Exchanges
Address
7 Times Square, 43rd Floor, New York, NY, USA, 10036
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is comprised of an experienced team of biotech and pharma executives who are leading the next generation of antibody complement therapeutics, aiming to deliver transformative medicines for people living with severe autoimmune diseases.

Dianthus Therapeutics (Dianthus Therapeutics) Headlines